Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

303
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
303
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

412
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
412
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

891
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
891

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study.

Open forum infectious diseases·2026
Same author

Bordetella pertussis: emerging epidemiology, diagnosis and management.

Pathology·2026
Same author

Management of Norovirus Infection in Solid Organ Transplant Recipients: A Scoping Review.

Transplantation direct·2026
Same author

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Antimicrobial agents and chemotherapy·2026
Same author

Molecular diagnostic tests for isoniazid-resistant tuberculosis: a scoping review.

The Lancet. Microbe·2026
Same author

Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 Epidemic.

The Journal of infectious diseases·2026
Same journal

Correction: Thaochan et al. Fungal-Infected Weeds: A Potential Source of Leaf Spot Disease in Rubber Trees from Southern Thailand. <i>J. Fungi</i> 2025, <i>11</i>, 220.

Journal of fungi (Basel, Switzerland)·2026
Same journal

Distinct Phenotype and Secondary Metabolite Profile Mark a Dominant <i>Aspergillus flavus</i> Outbreak Strain.

Journal of fungi (Basel, Switzerland)·2026
Same journal

Morphology, Chemistry, and Phylogeny Reveal Two New Species of the Genus <i>Lecidella</i> (Ascomycota, Lecanoraceae) from Anhui Province, China.

Journal of fungi (Basel, Switzerland)·2026
Same journal

Unlocking the Biocontrol Potential of Indigenous Soil Fungi: High-Performing Strains of <i>Beauveria bassiana</i> and <i>Metarhizium robertsii</i> Against the Tomato Leafminer <i>Tuta absoluta</i>.

Journal of fungi (Basel, Switzerland)·2026
Same journal

Unraveling CARD9 Mutations in Deep Dermatophytosis: A Genetic Gateway to Fungal Invasion and Immune Dysfunction.

Journal of fungi (Basel, Switzerland)·2026
Same journal

Draft Genome and Comparative Analysis of a <i>Cutaneotrichosporon jirovecii</i>-Related Yeast Recovered from a Human Fecal Sample.

Journal of fungi (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Aug 22, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

508

Pulmonary Cryptococcosis.

Annaleise R Howard-Jones1,2,3, Rebecca Sparks1, David Pham1

  • 1Centre for Infectious Diseases & Microbiology Laboratory Services, New South Wales Health Pathology-Institute of Clinical Pathology & Medical Research, Westmead Hospital, Westmead, NSW 2145, Australia.

Journal of Fungi (Basel, Switzerland)
|November 10, 2022
PubMed
Summary
This summary is machine-generated.

Pulmonary cryptococcosis, a serious lung infection from Cryptococcus, affects many populations and can mimic cancer. Early diagnosis and treatment, including antifungal therapy, are crucial for better outcomes.

Keywords:
antifungal agentscryptococcosisdiagnosisimmunosuppression

More Related Videos

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

460
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.8K

Related Experiment Videos

Last Updated: Aug 22, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

508
Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

460
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.8K

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary cryptococcosis is an invasive fungal infection of the lungs caused by Cryptococcus neoformans or Cryptococcus gattii.
  • It poses a significant threat to both immunocompromised and immunocompetent individuals, often being misdiagnosed as lung cancer, which delays treatment.
  • The epidemiology mirrors that of cryptococcal meningoencephalitis, with geographic variations in Cryptococcus gattii infections.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and management of pulmonary cryptococcosis.
  • To highlight the importance of diagnostic tools and appropriate treatment strategies.
  • To discuss the role of novel diagnostics and therapeutics in improving patient outcomes.

Main Methods:

  • Review of diagnostic modalities including histopathology, microscopy, culture, antigen detection, and nucleic acid testing.
  • Emphasis on the role of radiology in detection and diagnosis.
  • Discussion of treatment regimens, including induction and consolidation therapy, and the importance of susceptibility testing.

Main Results:

  • Pulmonary cryptococcosis requires comprehensive diagnostic approaches, combining laboratory tests with radiological findings.
  • Central nervous system involvement must be excluded in all cases through lumbar puncture and cerebral imaging.
  • Effective management involves prolonged antifungal therapy, with amphotericin B, flucytosine, and fluconazole being key agents.

Conclusions:

  • Pulmonary cryptococcosis is a severe condition necessitating prompt diagnosis and aggressive management.
  • Integrated diagnostic strategies and tailored therapeutic regimens are essential for successful treatment.
  • Advancements in diagnostics and therapeutics hold promise for improving care, especially in high-burden, low-income regions.